Botox, the wrinkle treatment made by Allergan, has been approved to treat adults with overactive bladders who cannot tolerate or were not helped by other drugs, the Food and Drug Administration said on Friday. Botox injected into the bladder muscle causes the bladder to relax, increasing its storage capacity. “Clinical studies have demonstrated Botox’s ability to significantly reduce the frequency of urinary incontinence,” Dr. Hylton V. Joffe, director of the F.D.A.’s reproductive and urologic products division, said in a statement. “Today’s approval provides an important additional treatment option for patients with overactive bladder, a condition that affects an estimated 33 million men and women in the United States.”
Business Briefing | Medicine: F.D.A. Clears Botox to Help Bladder Control
This article
Business Briefing | Medicine: F.D.A. Clears Botox to Help Bladder Control
can be opened in url
http://signaturesnews.blogspot.com/2013/01/business-briefing-medicine-fda-clears.html
Business Briefing | Medicine: F.D.A. Clears Botox to Help Bladder Control
